JPRN-UMIN000009596已完成未知
Withdrawal of immunomodulator in Crohn's disease treated with adalimumab and immnomodulator : a multicenter randomized trial(Diamond2 study). - Withdrawal of immunomodulator in Crohn's disease treated with adalimumab and immnomodulator : a multicenter randomized trial.
Department of Internal Medicine, School of Medicine, Keio University0 个研究点目标入组 200 人开始时间: 2012年12月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The patient is below 15 years of age 2. The patient is pregnant or lactating 3. The patient has an artificial anus 4. The period after the patient underwent gastrointestinal surgery is within 6 months 5. The patient has short-bowel syndrome 6. The patient has an imminent CD-related surgery 7. The patient has malignant tumor 8. The patient was judged not eligible by the investigator.
研究者
相似试验
已完成
4 期
The influence of medication for Crohn's disease on serological response to the influenza vaccinatios diseaseCrohn's diseaseJPRN-UMIN000008043The Jikei University School of Medicine Division of Gastroenterology and Hepatology150
招募中
4 期
Stopping anti-TNF treatment in Crohn's and Colitis patients in remissionUlcerative colitis2024-513299-17-00Region Skane350
进行中（未招募）
不适用
Treatment of Crohn’s disease-associated refractory diarrhoea with octreotide LARAn open pilot studyCrohn Disease refractory diarrhoeaMedDRA version: 12.1Level: LLTClassification code 10066533Term: Diarrhea recurrentEUCTR2010-023347-14-BEGastroenterology CHC Liege
进行中（未招募）
1 期
An investigational study to assess the safety and effectiveness of continuing existing 5-ASA medication versus stopping it.Inactive Crohn’s DiseaseEUCTR2018-001382-17-GBAlimentiv Inc1,580
已完成
4 期
A randomized controlled withdrawal trial in Crohn's disease patients in long-term remission on mesalazine: the CROWN study10017969Crohn's DiseaseNL-OMON36566niversitair Medisch Centrum Utrecht906